News | 12 November 2012
The industry has talked nonstop for a couple of years about the patent loss of blockbuster drugs and the impact, earnings losses, job cuts, R&D retrenchment, job losses, CEO job losses. In fact, this year has been the worst, literally. Industry ...
Click on the link to read the full article at FiercePharma
(This link will open in a new window)